Advertisement
U.S. markets closed

Zymeworks Inc. (ZYME)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
10.52+0.22 (+2.14%)
At close: 04:00PM EDT
10.52 0.00 (0.00%)
After hours: 04:11PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close10.30
Open10.35
Bid10.50 x 300
Ask10.54 x 100
Day's Range10.34 - 10.57
52 Week Range6.01 - 13.14
Volume440,419
Avg. Volume570,055
Market Cap742.377M
Beta (5Y Monthly)1.15
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ZYME

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Zymeworks Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    21 hours agoMorningstar
View more
  • We're sorry we weren't able to find anything about this topic.